<p>Cabozantinib is a kinase inhibitor indicated for the treatment of-</p>

<ul>
	<li>Patients with advanced renal cell carcinoma (RCC)</li>
	<li>Patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib</li>
</ul>